Q1 2022 Coloplast A/S Earnings Call Transcript
Welcome to the Coloplast Interim Financial Statements for Q1 2021/'22. (Operator Instructions)
Today, I am pleased to present Kristian Villumsen, President and CEO; and Anders Lonning-Skovgaard, Executive Vice President and CFO. Please begin your meeting.
/-&
Good afternoon, and welcome to our Q1 '21/'22 conference call. I'm Kristian Villumsen, the CEO of Coloplast, and I'm joined by our CFO, Anders Lonning-Skovgaard, and our Investor Relations team. We will start like we usually do with a short presentation by Anders and myself and then open up for questions.
Please turn to Slide #3. I'm very satisfied with the solid start to the year amidst the ongoing pandemic. We delivered 6% organic growth, a 32% EBIT margin before special items and a return on invested capital of 43% after tax and before special items.
Broadly, across all markets, we continue to take share and help more people with intimate health care needs. To start off, let me
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

